image: This figure illustrates the study sampling workflow. After collecting all overnight urine from 10:00 pm, participants take an oral glucose or steamed bread load at baseline (0 h, 8:00 am), with venous blood sampled at 0, 0.5, 1, 2, and 3 hours post-load. Urine specimens are collected at 1, 2, and 3 hours for volume measurement and detection of urinary C-peptide and creatinine. Cumulative urinary indices over 0–2 h and 0–3 h intervals are calculated for non-invasive pancreatic β-cell function assessment.
Credit: Dr. Qi Fu from the First Affiliated Hospital with Nanjing Medical University, China Image link: https://cdn-links.lww.com/permalink/cm9/c/CM9_2026_8_11_Yang_CMJ-2024-2567_SDC2.pdf
Progressive decline in pancreatic β-cell insulin secretion lies at the core of type 2 diabetes pathophysiology. Accurate β-cell function assessment is critical for diagnosis and personalized treatment, yet gold-standard load tests rely on repeated venous sampling, limiting patient compliance and routine clinical use. Practical non-invasive methods remain an unmet clinical need.
C-peptide is co-secreted with insulin in equimolar amounts by β-cells. Unlike insulin, it undergoes minimal hepatic metabolism and is excreted abundantly in urine, making urinary C-peptide (UCP) a well-recognized non-invasive marker of endogenous insulin secretion. While 24-hour UCP collection delivers high accuracy, its cumbersome protocol restricts real-world use. The UCP creatinine ratio (UCPCR) serves as a common alternative, but the optimal timing and reliability of post-load UCP testing remain unclear.
Led by Professor Qi Fu from the First Affiliated Hospital with Nanjing Medical University, China, the research team set out to identify the optimal urinary indicator and collection window, and to establish predictive equations for serum C-peptide. The study recruited two initial cohorts: 54 strictly screened subjects with normal glucose tolerance (NGT) and 270 adult patients with diabetes. A larger validation cohort of 700 hospitalized patients was also enrolled to confirm the findings. The study was published in Volume 139, Issue 18 of the Chinese Medical Journal on September 20, 2026.
All participants underwent 75-g oral glucose tolerance tests or steamed-bread mixed-meal tolerance tests, with blood samples collected at fasting and 0.5, 1, 2, 3 hours after the test. Hourly urine samples were collected simultaneously to measure C-peptide and creatinine, and urine volume was recorded to calculate cumulative urinary indices over 0–2 hours and 0–3 hours. Twelve NGT subjects also received Botnia clamp testing—the reference standard combining intravenous glucose tolerance test and hyperinsulinemic-euglycemic clamp—to independently verify insulin secretion phases and sensitivity.
Results showed that hourly UCP excretion closely mirrored the dynamic changes of serum C-peptide levels. Cumulative 3-hour UCP quantity (UCPQ0–3h) exhibited significantly stronger correlations with serum insulin and C-peptide area under curve (AUC) than spot UCPCR measurements, consistently in both NGT and diabetes groups.
Botnia clamp validation confirmed this advantage: UCPQ0–3h showed robust associations with both first-phase and second-phase insulin secretion (R² = 0.443 and 0.750, respectively) as well as insulin sensitivity, while UCPCR yielded notably weaker correlations. The 700-patient validation cohort replicated this finding, with UCPQ0–3h correlating with serum C-peptide AUC at r = 0.558 versus r = 0.497 for UCPCR.
Further residual analysis identified estimated glomerular filtration rate, glycated hemoglobin, and body weight as key factors influencing the UCP–serum C-peptide relationship. Incorporating these factors plus sex into the prediction model raised the coefficient of determination R² from 0.328 to 0.516, substantially improving prediction accuracy.
Dr. Fu noted that the volume-corrected 3-hour cumulative UCP provides a more reliable non-invasive measure of endogenous insulin secretion, reducing the burden of repeated blood sampling for diabetes follow-up and epidemiological research. The team added that 3-hour urine collection is currently most feasible in inpatient settings, and further validation in special populations such as pregnant women and children is warranted.
***
Reference
Title of original paper: Non-invasive methods for β-cell function assessment using a urine C-peptide model corrected for urine volume
Journal: Chinese Medical Journal
DOI: 10.1097/CM9.0000000000004207
About Associate Professor Qi Fu from the First Affiliated Hospital with Nanjing Medical University, China
Dr. Qi Fu is an Associate Chief Physician, Associate Professor, and Doctoral Supervisor at the Department of Endocrinology, the First Affiliated Hospital with Nanjing Medical University. He has long been engaged in research on the mechanisms of pancreatic islet injury and islet dysfunction in diabetes, as well as islet protection.
Funding information
This study was supported by grants from Non-communicable Chronic Diseases- National Science and Technology Major Project (No. 2023ZD0507000), the National Key Research and Development Program of China (No. 2024YFA1802900), and the National Natural Science Foundation of China (No. 82200888).
Journal
Chinese Medical Journal
Method of Research
Observational study
Subject of Research
People
Article Title
Non-invasive methods for β-cell function assessment using a urine C-peptide model corrected for urine volume
Article Publication Date
20-Sep-2026